Inside Track: A Fresh Look at Colorectal Cancer
David A. Ahlquist, MD, coinventor of the Cologuard stool-based DNA screening test for colorectal cancer, discusses updated USPSTF guidelines that seek to increase screening rates.
Read MorePosted by Elaine Sanchez Wilson | Jul 31, 2016 | Cancer, Cerebrovascular, Colorectal, Pancreatic, Stroke |
David A. Ahlquist, MD, coinventor of the Cologuard stool-based DNA screening test for colorectal cancer, discusses updated USPSTF guidelines that seek to increase screening rates.
Read MorePosted by Elaine Sanchez Wilson | Jul 26, 2016 | Uncategorized |
Following initial clearance in March for detection and differentiation of carbapenemase genes in pure bacterial isolates, the latest clearance extends use of the assay to the analysis of direct rectal swab specimens.
Read MorePosted by Steve Halasey | Jul 25, 2016 | Cancer, Leukemia, Molecular Diagnostics |
Agency allows marketing of the QuantideX qPCR BCR-ABL IS kit, the first nucleic acid-based quantitation test for use during treatment of rare leukemia.
Read MorePosted by Elaine Sanchez Wilson | Jul 8, 2016 | Immunoassay, Immunoassay Instrumentation, Microbiology Instruments |
Keeping pace with emerging biomarkers, and consolidating a broad test menu, are both important for developing and updating immunoassay instruments and kits.
Read MorePosted by Elaine Sanchez Wilson | Jun 21, 2016 | Cardiovascular |
The 84-gene panel is designed to identify patients with a genetic signature for inherited premature coronary or atherosclerotic disease, such as familial hypercholesterolemia, as well as mature onset diabetes of the young.
Read More